Gilead Sciences, Inc. (BCBA:GILD)

Gilead Sciences Ratios and Metrics

Market cap in millions ARS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 9, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	256,882,156	118,686,222	81,609,672	19,072,152	9,353,177	6,141,139
Market Cap Growth	111.47%	45.43%	327.90%	103.91%	52.30%	24.76%
Enterprise Value	276,552,074	135,664,730	94,367,518	22,203,527	11,404,841	6,332,948
Last Close Price	55125.00	26754.45	19060.14	7009.31	3468.10	1889.94
PE Ratio	23.11	239.83	17.82	23.45	14.63	593.74
PS Ratio	6.44	4.00	3.72	3.95	3.34	2.96
PB Ratio	8.74	5.98	4.44	5.08	4.32	4.01
P/FCF Ratio	20.46	11.17	13.60	12.91	8.43	9.71
P/OCF Ratio	19.39	10.63	12.61	11.87	8.00	8.94
EV/Sales Ratio	6.76	4.58	4.31	4.60	4.07	3.05
EV/EBITDA Ratio	13.75	9.78	9.75	9.59	7.94	6.05
EV/EBIT Ratio	17.30	12.31	12.58	11.42	9.31	6.87
EV/FCF Ratio	22.02	12.77	15.73	15.02	10.28	10.02
Debt / Equity Ratio	1.16	1.42	1.13	1.22	1.30	1.76
Debt / EBITDA Ratio	1.74	2.01	2.11	1.95	1.93	2.55
Debt / FCF Ratio	2.72	2.65	3.46	3.09	2.53	4.27
Asset Turnover	0.52	0.48	0.43	0.42	0.40	0.38
Inventory Turnover	3.39	3.58	3.66	3.62	3.35	2.83
Quick Ratio	1.11	1.33	1.15	1.03	1.02	1.20
Current Ratio	1.45	1.60	1.43	1.29	1.27	1.40
Return on Equity (ROE)	40.71%	2.29%	25.54%	21.60%	31.57%	0.44%
Return on Assets (ROA)	12.57%	11.03%	9.25%	10.46%	10.94%	10.54%
Return on Invested Capital (ROIC)	24.42%	19.78%	18.93%	21.25%	21.68%	1.80%
Return on Capital Employed (ROCE)	24.60%	22.70%	18.20%	21.10%	21.20%	19.20%
Earnings Yield	4.33%	0.42%	5.61%	4.26%	6.83%	0.17%
FCF Yield	4.89%	8.95%	7.35%	7.75%	11.86%	10.29%
Dividend Yield	1.15%	11.87%	12.72%	7.38%	8.41%	12.10%
Payout Ratio	49.10%	816.25%	67.24%	80.77%	57.91%	2804.07%
Buyback Yield / Dilution	-1.02%	0.24%	0.32%	0.08%	0.08%	1.10%
Total Shareholder Return	0.12%	12.11%	13.04%	7.46%	8.49%	13.20%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.